Federal Circuit vacates “skinny label” ruling

Ben Remaly

09 February 2021

Shutterstock/Bill Perry

The US Court of Appeals for the Federal Circuit has withdrawn a ruling that was criticised by some commentators for enhancing the risk of patent infringement liability for certain generic pharmaceutical companies.

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

Already have access? Login below

Ben Remaly

View full biography

Author | Editor, GCR USA

[email protected]

Tipline

The partiality of Judge Khan: The Tipline for 26 September 2022
Meta Platforms failed to get Federal Trade Commission chair Lina Khan recused from the agency’s monopolisation lawsuit. That has not stopped the technology company from also trying to push her out of the commission’s challenge to its acquisition of virtual reality startup Within Unlimited. Meta is arguing for a different outcome in this case based on the possibility that it may end up before the FTC’s internal tribunal.
Defying gravity: The Tipline for 23 September 2022
All the President’s Men: The Tipline for 22 September 2022

Federal Circuit vacates “skinny label” ruling

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Already have access? Login below

Related Topics

Ben Remaly